What are you looking for?
9781138080263

Drug Discovery and Development 3rd Edition by James J. O’Donnell

$18.85

✓Free EPUB conversionAsk any time and we convert it for your device.
✓Right edition guaranteedWrong edition or ISBN? Free swap.
✓Help any day, any hourFile will not open? We fix it or refund you.
✓Buy once, keep itNo subscription, no app, no expiry date.
Author
James J. O'Donnell
Edition
3rd
Publisher
CRC Press
ISBN
978-1138080263
Need another format after purchase? Email us and we will convert it for free
Loading payment options…
Description

Drug Discovery and Development, Third Edition

Book Details:
Editor: James J. O’Donnell
Edition: 3rd Edition
Publisher: CRC Press
ISBN-13: 978-1351625142
Publication Date: November 21, 2019

Drug Discovery and Development, Third Edition provides a comprehensive and up-to-date scientific framework for multidisciplinary research teams aiming to navigate the complex journey of bringing new therapeutic agents to the marketplace. This edition explores the latest scientific advances in the field, covering critical areas such as high-throughput screening technologies, innovative biotechnology approaches, and the rigorous evaluation of drug candidate efficacy and safety during preclinical testing.

This volume significantly expands its scope to include the clinical pharmacology, regulatory, and business dimensions of the industry, offering essential guidance for companies and researchers involved in modern drug development. By blending historical perspectives with predicted future trends, the text offers a holistic view of the pharmaceutical landscape, from initial discovery to commercialization.

Key Features:

  • Emerging Scientific Fields: Detailed coverage of cutting-edge areas including the microbiome, nanotechnology, and cancer immunotherapy.
  • Novel Research Tools: Exploration of transformative technologies such as CRISPR gene editing and DNA-encoded libraries.
  • In-Depth Case Study: A comprehensive look at the discovery and development process of the anti-cancer drug, lorlatinib.
  • Strategic Insights: Expert commentary from venture capitalists on the latest trends and best practices for successful drug discovery and development.